Stocks
ABIOMED (ABMD) ROE US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 16.3% | 27.6% | 19.1% | 17.0% | 9.08% | 17.3% | ||
| Changes by years, y/y, % | +5pp | +11pp | -9pp | -2pp | -8pp | -4.7% | |||
ABIOMED. ROE, %
ABIOMED. ROE, changes, pp
ABIOMED (ABMD) ROE US GAAP (quarter values) |
||||||||
| FY2022Q2 | FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | LTM ? | |||
| ROE, % | ? | 10.8% | 9.28% | 9.08% | 14.2% | 17.3% | 17.3% | |
| Changes by years, y/y, % | -7pp | -7pp | -8pp | +2pp | +7pp | |||
| Changes by quarters, q/q, % | -1pp | -1pp | 0pp | +5pp | +3pp | |||
